Wilhelmina International, Inc. (WHLM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1162836,
    "name": "Wilhelmina International, Inc.",
    "stock_name": "Wilhelmina International, Inc.",
    "full_name": "Wilhelmina International, Inc.",
    "name_url": "stocks-analysis/wilhelmina-international-inc",
    "exchange": 210,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "3.10",
    "chg": 0.1,
    "chgp": "3.33%",
    "dir": 1,
    "prev_price": "3.00",
    "mcapval": "18.70",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Miscellaneous",
    "ind_code": 3205,
    "indexname": "S&P 500",
    "isin": "US9682352003",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "200 ",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/wilhelmina-international-inc-1162836-210&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3723396",
        "imagepath": "",
        "date": "2025-11-23 11:11:46",
        "description": "As of 21 November 2025, the valuation grade for Wilhelmina International, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its current P/E ratio of 21, which is significantly higher than the peer average P/E of approximately 18.70, and an EV to EBITDA ratio of 8.84, which is also elevated compared to its peers. Additionally, the PEG ratio of 0.25 suggests that the company's growth prospects may not justify its current valuation.\n\nIn comparison to its peers, Wilhelmina's ROE of 2.74% and ROCE of 5.97% are relatively low, further supporting the notion of overvaluation. Notably, the stock has underperformed against the S&P 500, with a year-to-date return of -22.54% compared to the index's positive return of 12.26%. This performance reinforces the view that the stock is currently overvalued...."
      },
      {
        "title": "Wilhelmina International Adjusts Valuation Amidst Mixed Financial Performance Indicators",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wilhelmina-international-upgraded-to-hold-as-valuation-improves-despite-declining-sales-3673946",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/WilhelminaInter_mojoScore_3673946.png",
        "date": "2025-11-05 15:33:09",
        "description": "Wilhelmina International, Inc. has recently experienced a valuation grade adjustment, reflecting a more favorable assessment based on key financial metrics. Despite challenges in management efficiency and profitability, the company's valuation ratios suggest stability, while recent financial performance has shown a decline in net sales over the past five years."
      },
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3673432",
        "imagepath": "",
        "date": "2025-11-05 11:11:30",
        "description": "As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, supported by a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA ratio of 8.84. In comparison, its peer Wilhelmina International, Inc. has a lower P/E of approximately 18.70, suggesting that it is trading at a discount relative to its industry peers.\n\nWhile the stock has underperformed against the S&P 500 over the longer term, with a year-to-date return of -15.49% compared to the S&P 500's 16.30%, it has shown some resilience in the short term with a 1-week return of 1.69% versus the S&P 500's 0.71%. Overall, the current valuation metrics and peer comparisons suggest that Wilhelmina International, Inc. is positioned as an attractive investment opportunity...."
      },
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3670625",
        "imagepath": "",
        "date": "2025-11-04 11:17:29",
        "description": "As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. moved from very expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued based on its metrics. Key ratios include a P/E Ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84, which suggest that the stock is trading at a discount relative to its earnings and book value.\n\nIn comparison to peers, Wilhelmina International, Inc. has a more favorable P/E ratio than Coya Therapeutics, Inc. at -5.23 and a better EV to EBITDA ratio than Team, Inc. at 9.80. This positions Wilhelmina as an attractive investment within its industry. Although specific return data is not available, the overall valuation narrative suggests that the stock may have underperformed against the S&P 500, reinforcing the notion that it is currently undervalued...."
      },
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3666195",
        "imagepath": "",
        "date": "2025-11-03 11:16:52",
        "description": "As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, supported by a P/E ratio of 21, a price-to-book value of 0.83, and an EV to EBITDA ratio of 8.84. In comparison, its peer Coya Therapeutics, Inc. has a P/E of approximately 18.70, suggesting that Wilhelmina's valuation is relatively competitive within its industry.\n\nDespite the attractive valuation metrics, the company's recent stock performance has been underwhelming, with a year-to-date return of -15.49% compared to a positive return of 16.30% for the S&P 500. This stark contrast in returns over the same period reinforces the notion that Wilhelmina International, Inc. may be undervalued relative to its market performance and peer comparisons...."
      },
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3664326",
        "imagepath": "",
        "date": "2025-11-02 11:09:54",
        "description": "As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued based on its current metrics, with a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84. In comparison, its peer Wilhelmina International has a lower P/E of approximately 18.70 and a significantly lower EV to EBITDA of 6.74, suggesting that Wilhelmina is priced more attractively relative to its peers.\n\nDespite recent stock performance showing a decline of 15.49% year-to-date compared to a 16.30% gain in the S&P 500, the valuation ratios imply that the stock may present a buying opportunity. The PEG ratio of 0.25 further supports the notion of undervaluation, as it indicates that the stock is priced low relative to its expected growth. Overall, Wilhelmina International, Inc. i..."
      },
      {
        "title": "Wilhelmina International Adjusts Valuation Amidst Profitability Challenges and Declining Sales",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/wilhelmina-international-stock-rating-upgraded-from-sell-to-hold-amid-valuation-shift-3652485",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/WilhelminaInter_mojoScore_3652485.png",
        "date": "2025-10-28 19:04:15",
        "description": "Wilhelmina International, Inc. has recently experienced a change in its evaluation grade, reflecting a more favorable classification. Key financial metrics include a P/E ratio of 21 and a Price-to-Book Value of 0.83, though the company faces profitability challenges and declining net sales over the past five years."
      },
      {
        "title": "Is Wilhelmina International, Inc. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-wilhelmina-international-inc-overvalued-or-undervalued-3651091",
        "imagepath": "",
        "date": "2025-10-28 11:12:41",
        "description": "As of 24 October 2025, the valuation grade for Wilhelmina International, Inc. moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued based on its current metrics, with a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84. In comparison, its peer Coya Therapeutics, Inc. has a P/E of approximately 18.70, while Team, Inc. shows a higher EV to EBITDA of 9.80, suggesting that Wilhelmina may offer better value relative to its peers.\n\nDespite its attractive valuation, Wilhelmina has underperformed against the S&P 500, with a year-to-date return of -16.9% compared to the index's 15.47%. This trend continues over longer periods, with a 3-year return of -24.16% versus the S&P's 78.85%, highlighting the challenges the company faces despite its attractive valuation metrics...."
      }
    ],
    "total": 12,
    "sid": "1162836",
    "stock_news_url": "https://www.marketsmojo.com/news/wilhelmina-international-inc-1162836"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-11-23 11:11:46

As of 21 November 2025, the valuation grade for Wilhelmina International, Inc. has moved from attractive to very expensive, indicating a shift towards overvaluation. The company appears to be overvalued based on its current P/E ratio of 21, which is significantly higher than the peer average P/E of approximately 18.70, and an EV to EBITDA ratio of 8.84, which is also elevated compared to its peers. Additionally, the PEG ratio of 0.25 suggests that the company's growth prospects may not justify its current valuation. In comparison to its peers, Wilhelmina's ROE of 2.74% and ROCE of 5.97% are relatively low, further supporting the notion of overvaluation. Notably, the stock has underperformed against the S&P 500, with a year-to-date return of -22.54% compared to the index's positive return of 12.26%. This performance reinforces the view that the stock is currently overvalued....

Wilhelmina International Adjusts Valuation Amidst Mixed Financial Performance Indicators

2025-11-05 15:33:09

Wilhelmina International, Inc. has recently experienced a valuation grade adjustment, reflecting a more favorable assessment based on key financial metrics. Despite challenges in management efficiency and profitability, the company's valuation ratios suggest stability, while recent financial performance has shown a decline in net sales over the past five years.

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-11-05 11:11:30

As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, supported by a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA ratio of 8.84. In comparison, its peer Wilhelmina International, Inc. has a lower P/E of approximately 18.70, suggesting that it is trading at a discount relative to its industry peers. While the stock has underperformed against the S&P 500 over the longer term, with a year-to-date return of -15.49% compared to the S&P 500's 16.30%, it has shown some resilience in the short term with a 1-week return of 1.69% versus the S&P 500's 0.71%. Overall, the current valuation metrics and peer comparisons suggest that Wilhelmina International, Inc. is positioned as an attractive investment opportunity....

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-11-04 11:17:29

As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. moved from very expensive to attractive, indicating a significant shift in its perceived value. The company is currently considered undervalued based on its metrics. Key ratios include a P/E Ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84, which suggest that the stock is trading at a discount relative to its earnings and book value. In comparison to peers, Wilhelmina International, Inc. has a more favorable P/E ratio than Coya Therapeutics, Inc. at -5.23 and a better EV to EBITDA ratio than Team, Inc. at 9.80. This positions Wilhelmina as an attractive investment within its industry. Although specific return data is not available, the overall valuation narrative suggests that the stock may have underperformed against the S&P 500, reinforcing the notion that it is currently undervalued....

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-11-03 11:16:52

As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued, supported by a P/E ratio of 21, a price-to-book value of 0.83, and an EV to EBITDA ratio of 8.84. In comparison, its peer Coya Therapeutics, Inc. has a P/E of approximately 18.70, suggesting that Wilhelmina's valuation is relatively competitive within its industry. Despite the attractive valuation metrics, the company's recent stock performance has been underwhelming, with a year-to-date return of -15.49% compared to a positive return of 16.30% for the S&P 500. This stark contrast in returns over the same period reinforces the notion that Wilhelmina International, Inc. may be undervalued relative to its market performance and peer comparisons....

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-11-02 11:09:54

As of 31 October 2025, the valuation grade for Wilhelmina International, Inc. has moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued based on its current metrics, with a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84. In comparison, its peer Wilhelmina International has a lower P/E of approximately 18.70 and a significantly lower EV to EBITDA of 6.74, suggesting that Wilhelmina is priced more attractively relative to its peers. Despite recent stock performance showing a decline of 15.49% year-to-date compared to a 16.30% gain in the S&P 500, the valuation ratios imply that the stock may present a buying opportunity. The PEG ratio of 0.25 further supports the notion of undervaluation, as it indicates that the stock is priced low relative to its expected growth. Overall, Wilhelmina International, Inc. i...

Wilhelmina International Adjusts Valuation Amidst Profitability Challenges and Declining Sales

2025-10-28 19:04:15

Wilhelmina International, Inc. has recently experienced a change in its evaluation grade, reflecting a more favorable classification. Key financial metrics include a P/E ratio of 21 and a Price-to-Book Value of 0.83, though the company faces profitability challenges and declining net sales over the past five years.

Is Wilhelmina International, Inc. overvalued or undervalued?

2025-10-28 11:12:41

As of 24 October 2025, the valuation grade for Wilhelmina International, Inc. moved from very expensive to attractive, indicating a shift towards a more favorable assessment. The company appears undervalued based on its current metrics, with a P/E ratio of 21, a Price to Book Value of 0.83, and an EV to EBITDA of 8.84. In comparison, its peer Coya Therapeutics, Inc. has a P/E of approximately 18.70, while Team, Inc. shows a higher EV to EBITDA of 9.80, suggesting that Wilhelmina may offer better value relative to its peers. Despite its attractive valuation, Wilhelmina has underperformed against the S&P 500, with a year-to-date return of -16.9% compared to the index's 15.47%. This trend continues over longer periods, with a 3-year return of -24.16% versus the S&P's 78.85%, highlighting the challenges the company faces despite its attractive valuation metrics....

View All News